C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/04 (2006.01) A61K 31/4709 (2006.01) A61P 3/04 (2006.01) A61P 3/10 (2006.01) A61P 9/10 (2006.01) C07D 401/12 (2006.01)
Patent
CA 2460865
Compounds of formula (I), as well as pharmaceutically acceptable salts and esters thereof, wherein R1, R2, R3, A1 and A2 have the significance given in claim 1, can be used in the form of pharmaceutical preparations for the treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders and obesity.
L'invention concerne des composés correspondant à la formule (I), ainsi que des sels et des esters pharmaceutiquement acceptables de ceux-ci. Dans ladite formule (I), R?1¿, R?2¿, R?3¿, A?1¿ et A?2¿ correspondent à la définition donnée dans la revendication 1. Ces composés, leurs sels et esters pharmaceutiquement acceptables peuvent être utilisés sous la forme de préparations pharmaceutiques pour le traitement ou la prévention de l'arthrite, de maladies cardio-vasculaires, du diabète, de l'insuffisance rénale, des troubles de l'alimentation et de l'obésité.
Klug Michael G.
Mattei Patrizio
Mueller Werner
Neidhart Werner
Nettekoven Matthias Heinrich
F. Hoffmann-La Roche Ag
Gowling Lafleur Henderson Llp
LandOfFree
Quinoline derivatives as neuropeptide y antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinoline derivatives as neuropeptide y antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinoline derivatives as neuropeptide y antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1722832